Little Rock, AR, United States of America

Y T Pan

This inventor holds 1 USPTO granted patent. Top assignee: University of Arkansas. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Y T Pan. Retrieved from https://idiyas.com/inventor/y-t-pan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Y T Pan: Inventor in Little Rock, Arkansas.

Introduction

Y T Pan is an inventor associated with the University of Arkansas in Little Rock, Arkansas. The supplied information identifies Pan as a woman and credits her with 1 patent.

Latest Patents

Pan’s listed patent, “Inhibition of Bacterial Binding by High-Mannose Oligosaccharides,” describes a proposed method for treating infections caused by gram-negative bacteria. It uses high-mannose oligosaccharides, including Man₉(GlcNAc)₂ attached to hydrophobic glycopeptides such as tyrosinamide, to interfere with bacterial adhesion to host-cell membranes. The described approach focuses on infections involving *Enterobacter cloacae* and other *Enterobacter* and gram-negative species.

Career Highlights

Pan’s patent work connects carbohydrate chemistry with a potential strategy for preventing bacterial attachment. The supplied information associates her with the University of Arkansas.

Collaborations

Sam Smith and Alan D. Elbein are identified as Pan’s coworkers.

Conclusion

Y T Pan’s listed invention explores the use of high-mannose oligosaccharides to block bacterial binding, reflecting a research focus on potential approaches to gram-negative infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…